VIP inhibits the proliferation of small-cell and nonsmall-cell lung carcinoma.
Maruno
K
K
Northport VA Medical Center, New York, USA.
Said
S I
SI
D000818:Animals; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology*; D018288:Carcinoma, Small Cell / Q000473:pathology*; D002452:Cell Count / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D051379:Mice; D008819:Mice, Nude; D013936:Thymidine / Q000378:metabolism; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured; D014660:Vasoactive Intestinal Peptide / Q000097:blood / Q000494:pharmacology*
D004273:DNA, Neoplasm; D014660:Vasoactive Intestinal Peptide; D013936:Thymidine